Because of the high incidence of agranulocytosis, 1Β±6 the aminopyrines have already been banned or withdrawn from the market in the western countries in the 1960s or 1970s. 7 Unfortunately, these drugs are still available in other parts of the world. 6 Spontaneous reports 7,8 and the results of some
β¦ LIBER β¦
Aminopyrine and blood dyscrasias
β Scribed by David W. Kaufman; Surapol Issaragrisil
- Book ID
- 101289495
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 34 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1053-8569
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Aminopyrine-induced blood dyscrasias
β
Thomas Y. K. Chan; Anthony W. K. Chan
π
Article
π
1998
π
John Wiley and Sons
π
English
β 58 KB
Aminopyrine-Induced Blood DyscrasiasβSti
β
Thomas Y. K. Chan; Anthony W. K. Chan
π
Article
π
1996
π
John Wiley and Sons
π
English
β 406 KB
The aminopyrines were introduced about a century ago as analgesics and antipyretics, but it was not until the 1930s that agranulocytosis, their major adverse reaction, was recognized. In patients receiving aminopyrines, although agranulocytosis is the most frequent blood dyscrasia, aplastic anaemia
Pharmacogenetics and blood dyscrasias
β
Dr. Stephen P. Spielberg
π
Article
π
2009
π
John Wiley and Sons
π
English
β 568 KB
Mianserin and blood dyscrasias.
β
HM Clink
π
Article
π
1983
π
John Wiley and Sons
π
English
β 295 KB
Clozapine and blood dyscrasia
β
Latif, Z.; Jabbar, F.; Kelly, B. D.
π
Article
π
2011
π
The Royal College of Psychiatrists
π
English
β 67 KB
Procainamide-associated blood dyscrasias
β
Julie Danielly; Richard DeJong; Lyn C. Radke-Mitchell; Andrew C.G. Uprichard
π
Article
π
1994
π
Elsevier Science
π
English
β 261 KB